Leukoencephalopathy With Vanishing White Matter: A Review
The DOI matches its Crossref record; 108 of the 109 references it cites were found in a registry or an index.
Abstract
Vanishing white matter (VWM) is one of the most prevalent inherited childhood leukoencephalopathies, but this may affect people of all ages, including neonates and adults. It is a progressive disorder clinically dominated by cerebellar ataxia and in which minor stress conditions, such as fever or mild trauma, provoke major episodes of neurologic deterioration. Typical pathological findings include increasing white matter rarefaction and cystic degeneration, oligodendrocytosis with highly characteristic foamy oligodendrocytes, meager astrogliosis with dysmorphic astrocytes, and loss of oligodendrocytes by apoptosis. Vanishing white matter is caused by mutations in any of the genes encoding the 5 subunits of the eukaryotic translation initiation factor 2B (eIF2B), EIF2B1 through EIF2B5. eIF2B is a ubiquitously expressed protein complex that plays a crucial role in regulating the rate of protein synthesis. Vanishing white matter mutations reduce the activity of eIF2B and impair its function to couple protein synthesis to the cellular demands in basal conditions and during stress. Reduced eIF2B activity leads to sustained improper activation of the unfolded protein response, resulting in concomitant expression of proliferation, prosurvival, and proapoptotic downstream effectors. Consequently, VWM cells are constitutively predisposed and hyperreactive to stress. In view of the fact that VWM genes are housekeeping genes, it is surprising that the disease is primarily a leukoencephalopathy. The pathophysiology of selective glial vulnerability in VWM remains poorly understood.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Mutations in EIF2B1-5 genes, encoding subunits of eIF2b, responsible for protein translation, lead to leukoencephalopathy with vanishing white matter characterized by progressive degeneration of white matter due to myelination failure and impairments in oligodendrocyte function (Bugiani et al., 2010).”
From Alzheimer's-associated PU.1 expression levels regulate microglial inflammatory response (2021) · cites this paper as Bugiani et al., 2010
Citations
Cites
Protein translation and folding are coupled by an endoplasmic-reticulum-resident kinase
Harding, H. P., Zhang, Y., & Ron, D. (1999) · Nature · doi:10.1038/16729 · Cited by 3,310 · cited 1×
“Some mRNAs are exempt from inhibition through specific features in their 5¶ untranslated regions (104).”
BackgroundRegulated Translation Initiation Controls Stress-Induced Gene Expression in Mammalian Cells
Harding, H. P., Novoa, I., Zhang, Y., Zeng, H., Wek, R., Schapira, M., & Ron, D. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)00108-8 · Cited by 3,276
Roles of CHOP/GADD153 in endoplasmic reticulum stress
Oyadomari, S., & Mori, M. (2004) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401373 · Cited by 2,828
McCullough, K. D., Martindale, J. L., Klotz, L.-O., Aw, T.-Y., & Holbrook, N. J. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.4.1249-1259.2001 · Cited by 1,889
ER stress and the unfolded protein response
Schröder, M., & Kaufman, R. J. (2005) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/j.mrfmmm.2004.06.056 · Cited by 1,747
Feedback Inhibition of the Unfolded Protein Response by GADD34-Mediated Dephosphorylation of eIF2α
Novoa, I., Zeng, H., Harding, H. P., & Ron, D. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.153.5.1011 · Cited by 1,386
Welch, W. J. (1992) · Physiological Reviews · doi:10.1152/physrev.1992.72.4.1063 · Cited by 1,190
Lu, P. D., Harding, H. P., & Ron, D. (2004) · The Journal of Cell Biology · doi:10.1083/jcb.200408003 · Cited by 1,006 · cited 3×
“Novoa I, Zeng H, Harding HP, et al. Feedback inhibition of the unfolded protein response by GADD34-mediated dephosphorylation of eIF2alpha.”
BackgroundTranscriptional and Translational Control in the Mammalian Unfolded Protein Response
Harding, H. P., Calfon, M., Urano, F., Novoa, I., & Ron, D. (2002) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.18.011402.160624 · Cited by 918
Gene-Specific Regulation by General Translation Factors
Dever, T. E. (2002) · Cell · doi:10.1016/s0092-8674(02)00642-6 · Cited by 719
Leegwater, P. A. J., Vermeulen, G., Könst, A. A. M., Naidu, S., Mulders, J., Visser, A., Kersbergen, P., Mobach, D., Fonds, D., van Berkel, C. G. M., et al. (2001) · Nature Genetics · doi:10.1038/ng764 · Cited by 414
A new leukoencephalopathy with vanishing white matter
van der Knaap, M. S., Barth, P. G., Gabreëls, F. J. M., Franzoni, E., Begeer, J. H., Stroink, H., Rotteveel, J. J., & Valk, J. (1997) · Neurology · doi:10.1212/wnl.48.4.845 · Cited by 392
van der Knaap, M. S., Leegwater, P. A. J., Könst, A. A. M., Visser, A., Naidu, S., Oudejans, C. B. M., Schutgens, R. B. H., & Pronk, J. C. (2002) · Annals of Neurology · doi:10.1002/ana.10112 · Cited by 381
Krishnamoorthy, T., Pavitt, G. D., Zhang, F., Dever, T. E., & Hinnebusch, A. G. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.15.5018-5030.2001 · Cited by 335
Rowlands, A. G., Panniers, R., & Henshaw, E. C. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)60596-4 · Cited by 332
Vanishing white matter disease
van der Knaap, M. S., Pronk, J. C., & Scheper, G. C. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70440-9 · Cited by 324
Self-citationTranslation matters: protein synthesis defects in inherited disease
Scheper, G. C., van der Knaap, M. S., & Proud, C. G. (2007) · Nature Reviews Genetics · doi:10.1038/nrg2142 · Cited by 264
Self-citationChildhood ataxia with diffuse central nervous system hypomyelination
Schiffmann, R., Moller, J. R., Trapp, B. D., Shih, H. H., Farrer, R. G., Katz, D. A., Alger, J. R., Parker, C. C., Hauer, P. E., Kaneski, C. R., et al. (1994) · Annals of Neurology · doi:10.1002/ana.410350314 · Cited by 261
Defining and Categorizing Leukoencephalopathies of Unknown Origin: MR Imaging Approach
van der Knaap, M. S., Breiter, S. N., Naidu, S., Hart, A. A. M., & Valk, J. (1999) · Radiology · doi:10.1148/radiology.213.1.r99se01121 · Cited by 241
Initiation Factor eIF2α Phosphorylation in Stress Responses and Apoptosis
Clemens, M. J. (2001) · Progress in Molecular and Subcellular Biology · doi:10.1007/978-3-662-09889-9_3 · Cited by 218
Protein synthesis and protein phosphorylation during heat stress, recovery, and adaptation.
Duncan, R. F., & Hershey, J. W. (1989) · The Journal of cell biology · doi:10.1083/jcb.109.4.1467 · Cited by 207
Taniguchi, M., & Yoshida, H. (2011) · Comprehensive Biotechnology · doi:10.1016/b978-0-444-64046-8.00033-1 · Cited by 207
Liu, C. Y., & Kaufman, R. J. (2003) · Journal of Cell Science · doi:10.1242/jcs.00408 · Cited by 205
Ovarian Failure Related to Eukaryotic Initiation Factor 2B Mutations
Fogli, A., Rodriguez, D., Eymard-Pierre, E., Bouhour, F., Labauge, P., Meaney, B. F., Zeesman, S., Kaneski, C. R., Schiffmann, R., & Boespflug-Tanguy, O. (2003) · The American Journal of Human Genetics · doi:10.1086/375404 · Cited by 199
Phenotypic variation in leukoencephalopathy with vanishing white matter
van der Knaap, M. S., Kamphorst, W., Barth, P. G., Kraaijeveld, C. L., Gut, E., & Valk, J. (1998) · Neurology · doi:10.1212/wnl.51.2.540 · Cited by 196
Phenotypic variation in leukoencephalopathy with vanishing white matter
Rodriguez, D., Gelot, A., van der Knaap, M. S., & Kamphorst, W. (1999) · Neurology · doi:10.1212/wnl.53.6.1373 · Cited by 189
Hanefeld, F., Holzbach, U., Kruse, B., Wilichowski, E., Christen, H., & Frahm, J. (1993) · Neuropediatrics · doi:10.1055/s-2008-1071551 · Cited by 180
eIF2B-Related Disorders: Antenatal Onset and Involvement of Multiple Organs
van der Knaap, M. S., van Berkel, C. G. M., Herms, J., van Coster, R., Baethmann, M., Naidu, S., Boltshauser, E., Willemsen, M. A. A. P., Plecko, B., Hoffmann, G. F., et al. (2003) · The American Journal of Human Genetics · doi:10.1086/379524 · Cited by 170
Self-citationThe effect of genotype on the natural history of eIF2B-related leukodystrophies
Fogli, A., Schiffmann, R., Bertini, E., Ughetto, S., Combes, P., Eymard-Pierre, E., Kaneski, C. R., Pineda, M., Troncoso, M., Uziel, G., et al. (2004) · Neurology · doi:10.1212/01.wnl.0000123259.67815.db · Cited by 163
Li, W., Wang, X., van der Knaap, M. S., & Proud, C. G. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.8.3295-3306.2004 · Cited by 128
EIF2B5 mutations compromise GFAP+ astrocyte generation in vanishing white matter leukodystrophy
Dietrich, J., Lacagnina, M., Gass, D. A., Richfield, E. K., Mayer‐Pröschel, M., Noble, M., Torres, C., & Pröschel, C. (2005) · Nature Medicine · doi:10.1038/nm1195 · Cited by 127
Cree leukoencephalopathy and CACH/VWM disease are allelic at the EIF2B5 locus
Fogli, A., Wong, K., Eymard‐Pierre, E., Wenger, J., Bouffard, J., Goldin, E., Black, D. N., Boespflug‐Tanguy, O., & Schiffmann, R. (2002) · Annals of Neurology · doi:10.1002/ana.10339 · Cited by 125
Natural history of adult-onset eIF2B-related disorders: a multi-centric survey of 16 cases
Labauge, P., Horzinski, L., Ayrignac, X., Blanc, P., Vukusic, S., Rodriguez, D., Mauguiere, F., Peter, L., Goizet, C., Bouhour, F., et al. (2009) · Brain · doi:10.1093/brain/awp171 · Cited by 124
Diagnosis of inflammatory demyelination in biopsy specimens: a practical approach
Kuhlmann, T., Lassmann, H., & Brück, W. (2008) · Acta Neuropathologica · doi:10.1007/s00401-007-0320-8 · Cited by 116
The large spectrum of eIF2B-related diseases
Fogli, A., & Boespflug-Tanguy, O. (2006) · Biochemical Society Transactions · doi:10.1042/bst0340022 · Cited by 116
Diffusion-weighted MR imaging in leukodystrophies
Patay, Z. J. (2005) · European Radiology · doi:10.1007/s00330-005-2846-2 · Cited by 114
Richardson, J. P., Mohammad, S. S., & Pavitt, G. D. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.6.2352-2363.2004 · Cited by 110
van Kollenburg, B., van Dijk, J., Garbern, J., Thomas, A. A. M., Scheper, G. C., Powers, J. M., & van der Knaap, M. S. (2006) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/01.jnen.0000228201.27539.50 · Cited by 108
Self-citationCHOP plays a pivotal role in the astrocyte death induced by oxygen and glucose deprivation
Benavides, A., Pastor, D., Santos, P., Tranque, P., & Calvo, S. (2005) · Glia · doi:10.1002/glia.20242 · Cited by 107
The Unfolded Protein Response in Vanishing White Matter Disease
van der Voorn, J. P., van Kollenburg, B., Bertrand, G., Van Haren, K., Scheper, G. C., Powers, J. M., & van der Knaap, M. S. (2005) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/01.jnen.0000178446.41595.3a · Cited by 102
Self-citationVanishing white matter disease: A review with focus on its genetics
Pronk, J. C., van Kollenburg, B., Scheper, G. C., & van der Knaap, M. S. (2006) · Mental Retardation and Developmental Disabilities Research Reviews · doi:10.1002/mrdd.20104 · Cited by 100
Self-citationWong, K., Armstrong, R. C., Gyure, K. A., Morrison, A. L., Rodriguez, D., Matalon, R. K., Johnson, T., Wollmann, R. L., Gilbert, E., Le, T. Q., et al. (2000) · Acta Neuropathologica · doi:10.1007/s004010000234 · Cited by 99
Shutdown of Translation: Lethal or Protective? Unfolded Protein Response versus Apoptosis
Paschen, W. (2003) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/01.wcb.0000075009.47474.f9 · Cited by 98
Decreased guanine nucleotide exchange factor activity in eIF2B-mutated patients
Fogli, A., Schiffmann, R., Hugendubler, L., Combes, P., Bertini, E., Rodriguez, D., Kimball, S. R., & Boespflug‐Tanguy, O. (2004) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5201189 · Cited by 97
Regulation of Eukaryotic Initiation Factor eIF2B
Proud, C. G. (2001) · Progress in molecular and subcellular biology · doi:10.1007/978-3-642-56688-2_4 · Cited by 91
Eukaryotic initiation factor 2B (eIF2B)
Webb, B. L. J., & Proud, C. G. (1997) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(97)00039-3 · Cited by 90
Kantor, L., Harding, H. P., Ron, D., Schiffmann, R., Kaneski, C. R., Kimball, S. R., & Elroy‐Stein, O. (2005) · Human Genetics · doi:10.1007/s00439-005-0024-x · Cited by 88
Rodriguez, D., Gélot, A., Gaspera, B. D., Robain, O., Ponsot, G., Sarliève, L. L., Ghandour, S., Pompidou, A. J., Dautigny, A., Aubourg, P. R., et al. (1999) · Acta Neuropathologica · doi:10.1007/s004010051016 · Cited by 87
Tedeschi, G., Schiffmann, R., Barton, N. W., Shih, H., Gospe, S. M., Brady, R. O., Alger, J. R., & Chiro, G. D. (1995) · Neurology · doi:10.1212/wnl.45.8.1526 · Cited by 78
Leukodystrophy in patients with ovarian dysgenesis
Schiffmann, R., Tedeschi, G., Kinkel, R. P., Trapp, B. D., Frank, J. A., Kaneski, C. R., Brady, R. O., Barton, N. W., Nelson, L. M., & Yanovski, J. A. (1997) · Annals of Neurology · doi:10.1002/ana.410410515 · Cited by 77
The Life and Death of Oligodendrocytes in Vanishing White Matter Disease
Van Haren, K., Van Der Voorn, J. P., Peterson, D. R., Van Der Knaap, M. S., & Powers, J. M. (2004) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/63.6.618 · Cited by 76
Self-citationvan der Knaap, M. S., Wevers, R. A., Kure, S., Gabreëls, F. J. M., Verhoeven‐Duif, N. M., van Raaij‐Selten, B., & Jaeken, J. (1999) · Journal of Child Neurology · doi:10.1177/088307389901401108 · Cited by 73
Arg113His mutation in eIF2Bε as cause of leukoencephalopathy in adults
van der Knaap, M. S., Leegwater, P. A. J., van Berkel, C. G. M., Brenner, C., Storey, E., Rocco, M. D., Salvi, F., & Pronk, J. C. (2004) · Neurology · doi:10.1212/01.wnl.0000123118.86746.fc · Cited by 72
Schiffmann, R., & Elroy‐Stein, O. (2005) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2005.10.019 · Cited by 71
Fogli, A., Dionisi‐Vici, C., Deodato, F., Bartuli, A., Boespflug‐Tanguy, O., & Bertini, E. (2002) · Neurology · doi:10.1212/01.wnl.0000041666.76863.47 · Cited by 68
Adult-onset leukoencephalopathy with vanishing white matter with a missense mutation in EIF2B5
Ohtake, H., Shimohata, T., Terajima, K., Kimura, T., Jo, R., Kaseda, R., Iizuka, O., Takano, M., Akaiwa, Y., Goto, H., et al. (2004) · Neurology · doi:10.1212/01.wnl.0000123117.11264.0e · Cited by 62
Fright is a provoking factor in vanishing white matter disease
Vermeulen, G., Seidl, R., Mercimek‐Andrews, S., Rotteveel, J. J., Scheper, G. C., & van der Knaap, M. S. (2005) · Annals of Neurology · doi:10.1002/ana.20418 · Cited by 61
Self-citationFatal infantile leukodystrophy: A severe variant of CACH/VWM syndrome, allelic to chromosome 3q27
Black, D. N., Harris, R., Schiffmann, R., & Wong, K. (2002) · Neurology · doi:10.1212/wnl.58.1.161-a · Cited by 60
Adult‐onset leukoencephalopathy with vanishing white matter presenting with dementia
Prass, K., Brück, W., Schröder, N. W. J., Bender, A., Prass, M., Wolf, T., Van Der Knaap, M. S., & Zschenderlein, R. (2001) · Annals of Neurology · doi:10.1002/ana.1259 · Cited by 58
Leukoencephalopathy among native indian infants in northern Quebec and Manitoba
Black, D. N., Booth, F., Watters, G. V., Andermann, E., Dumont, C., Halliday, W. C., Hoogstraten, J., Kabay, M. E., Kaplan, P., Meagher‐Villemure, K., et al. (1988) · Annals of Neurology · doi:10.1002/ana.410240403 · Cited by 56
The spectrum of mutations for the diagnosis of vanishing white matter disease
Scali, O., Perri, C. D., & Federico, A. (2006) · Neurological Sciences · doi:10.1007/s10072-006-0683-y · Cited by 55
Inactivation of eIF2B and Phosphorylation of PHAS-I in Heat-shocked Rat Hepatoma Cells
Scheper, G. C., Mulder, J., Kleijn, M., Voorma, H. O., Thomas, A. A. M., & van Wijk, R. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.43.26850 · Cited by 55
Self-citationFatal infantile leukodystrophy: A severe variant of CACH/VWM syndrome, allelic to chromosome 3q27
Francalanci, P., Eymard–Pierre, E., Dionisi–Vici, C., Boldrini, R., Piemonte, F., Virgili, R., Fariello, G., Bosman, C., Santorelli, F. M., Boespflug–Tanguy, O., et al. (2001) · Neurology · doi:10.1212/wnl.57.2.265 · Cited by 55
Regulation of protein synthesis in lymphoblasts from vanishing white matter patients
van Kollenburg, B., Thomas, A. A. M., Vermeulen, G., Bertrand, G. A. M., van Berkel, C. G. M., Pronk, J. C., Proud, C. G., van der Knaap, M. S., & Scheper, G. C. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.08.009 · Cited by 54
Self-citationBrück, W., Herms, J., Brockmann, K., Schulz‐Schaeffer, W., & Hanefeld, F. (2001) · Annals of Neurology · doi:10.1002/ana.1227 · Cited by 54
Vanderver, A. L., Schiffmann, R., Timmons, M., Kellersberger, K. A., Fabris, D., Hoffman, E. P., Maletkovic, J., & Hathout, Y. (2005) · Clinical Chemistry · doi:10.1373/clinchem.2005.055053 · Cited by 53
Genetic and Clinical Heterogeneity in eIF2B-Related Disorder
Maletkovic, J., Schiffmann, R., Gorospe, J. R. M., Gordon, E. S., Mintz, M., Hoffman, E. P., Alper, G. P., Lynch, D. R., Singhal, B. S., Harding, C. O., et al. (2007) · Journal of Child Neurology · doi:10.1177/0883073807308705 · Cited by 52
Identification of ten novel mutations in patients with eIF2B-related disorders
Ohlenbusch, A., Henneke, M., Brockmann, K., Görg, M., Hanefeld, F. A., Kohlschütter, A., & Gärtner, J. (2005) · Human Mutation · doi:10.1002/humu.9325 · Cited by 49
Horzinski, L., Huyghe, A., Cardoso, M.-C., Gonthier‐Guéret, C., Ouchchane, L., Schiffmann, R., Blanc, P., Boespflug‐Tanguy, O., & Fogli, A. (2009) · PLoS ONE · doi:10.1371/journal.pone.0008318 · Cited by 47
Petrov, T., Underwood, B. D., Braun, B., Alousi, S. S., & Rafols, J. A. (2001) · Journal of Neurotrauma · doi:10.1089/089771501316919166 · Cited by 45
Leegwater, P. A. J., Pronk, J. C., & van der Knaap, M. S. (2003) · Journal of Child Neurology · doi:10.1177/08830738030180091101 · Cited by 44
Kantor, L., Pinchasi, D., Mintz, M., Hathout, Y., Vanderver, A. L., & Elroy‐Stein, O. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003783 · Cited by 41
Defective translation initiation causes vanishing of cerebral white matter
Scheper, G. C., Proud, C. G., & van der Knaap, M. S. (2006) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2006.02.006 · Cited by 39
Self-citationLeukoencephalopathy with vanishing white matter: An adult onset case
Biancheri, R., Rossi, A., Rocco, M. D., Filocamo, M., Pronk, J. C., van der Knaap, M. S., & Tortori‐Donati, P. (2003) · Neurology · doi:10.1212/01.wnl.0000098994.35677.3c · Cited by 36
Price, N. T., MELLOR, H., Craddock, B. L., Flowers, K. M., Kimball, S. R., Wilmer, T. E., Jefferson, L. S., & Proud, C. G. (1996) · Biochemical Journal · doi:10.1042/bj3180637 · Cited by 33
Membrane phospholipids and high-energy metabolites in childhood ataxia with CNS hypomyelination
Blüml, S., Philippart, M., Schiffmann, R., Seymour, K. J., & Ross, B. D. (2003) · Neurology · doi:10.1212/wnl.61.5.648 · Cited by 32
ADULT-ONSET VANISHING WHITE MATTER LEUKOENCEPHALOPATHY PRESENTING AS PSYCHOSIS
Denier, C., Orgibet, A., Roffi, F., Jouvent, É., Buhl, C. S., Niel, F., Boespflug‐Tanguy, O., Saïd, G., & Ducreux, D. (2007) · Neurology · doi:10.1212/01.wnl.0000260701.76868.44 · Cited by 32
Boltshauser, E., Barth, P. G., Troost, D., Martin, E., & Stallmach, T. (2002) · Neuropediatrics · doi:10.1055/s-2002-32363 · Cited by 28
Identification of novel EIF2B mutations in Chinese patients with vanishing white matter disease
Wu, Y., Pan, Y., Du, L. L., Wang, J., Gu, Q., Gao, Z., Li, J., Leng, X., Qin, J., Wu, X., et al. (2009) · Journal of Human Genetics · doi:10.1038/jhg.2008.10 · Cited by 28
Acute fright induces onset of symptoms in vanishing white matter disease—Case report
Kaczorowska, M., Kuczyński, D., Jurkiewicz, E., Scheper, G. C., van der Knaap, M. S., & Jóźwiak, S. (2006) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2006.05.008 · Cited by 28
Self-citationCAVITATING “DIFFUSE SCLEROSIS”
WATANABE, I., & Muller, J. (1967) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-196707000-00007 · Cited by 27
Mathis, S., Scheper, G. C., Baumann, N., Petit, E., Gil, R., van der Knaap, M. S., & Neau, J. (2008) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2008.06.002 · Cited by 25
Self-citationSensitivity and specificity of decreased CSF asialotransferrin for eIF2B-related disorder
Vanderver, A. L., Hathout, Y., Maletkovic, J., Gordon, E. S., Mintz, M., Timmons, M. A., Hoffman, E. P., Horzinski, L., Niel, F., Fogli, A., et al. (2008) · Neurology · doi:10.1212/01.wnl.0000313857.54398.0e · Cited by 24
A Japanese girl with leukoencephalopathy with vanishing white matter
Sugiura, C., Miyata, H., Oka, A., Takashima, S., Ohama, E., & Takeshita, K. (2001) · Brain and Development · doi:10.1016/s0387-7604(00)00198-4 · Cited by 22
Polycystische Umwandlung des Marklagers mit progredientem Verlauf: Atypische diffuse Sklerose?
Eicke, W. J. (1962) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/bf00352729 · Cited by 21
Cree Leukoencephalopathy: Neuroimaging Findings
Alorainy, I. A., Patenaude, Y. G., O’Gorman, A. M., Black, D. N., & Meagher‐Villemure, K. (1999) · Radiology · doi:10.1148/radiology.213.2.r99oc28400 · Cited by 20
Rosemberg, S., Leite, C. D. C., Arita, F. N., Kliemann, S., & de Lacerda, M. T. C. (2002) · Brain and Development · doi:10.1016/s0387-7604(02)00034-7 · Cited by 19
Late-Life Cavitating Dystrophy of the Cerebral and Cerebellar White Matter
Anzil, A. P., & Gessaga, E. C. (2008) · European Neurology · doi:10.1159/000114415 · Cited by 17
Peripheral neuropathy in vanishing white matter disease with a novel EIF2B5 mutation
Federico, A., Scali, O., Stromillo, M. L., Perri, C. D., Bianchi, S., Sicurelli, F., Stefano, N. D., Malandrini, A., & Dotti, M. T. (2006) · Neurology · doi:10.1212/01.wnl.0000225077.40532.a5 · Cited by 17
1H chemical shift imaging, MRI, and diffusion-weighted imaging in vanishing white matter disease
Sijens, P. E., Boon, M., Meiners, L. C., Brouwer, O. F., & Oudkerk, M. (2005) · European Radiology · doi:10.1007/s00330-005-2783-0 · Cited by 16
Dreha‐Kulaczewski, S. F., Dechent, P., Finsterbusch, J., Brockmann, K., Gärtner, J., Frahm, J., & Hanefeld, F. A. (2008) · Pediatric Research · doi:10.1203/01.pdr.0000304934.90198.25 · Cited by 16
Höhlenbildende Neutralfett-Leukodystrophie mit Schubverlauf
Deisenhammer, E., & Jellinger, K. A. (1976) · Neuropediatrics · doi:10.1055/s-0028-1091614 · Cited by 16
Intra-familial phenotypic heterogeneity in adult onset vanishing white matter disease
Damon‐Perrière, N., Ménégon, P., Anne, O., Boespflug‐Tanguy, O., Niel, F., Creveaux, I., Dousset, V., Brochet, B., & Goizet, C. (2008) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2008.08.003 · Cited by 15
Jc, G., Gray, F., Awada, A. A., & Escourolle, R. (1984) · PubMed · Cited by 15
Pf, G., Tommasi, M., Rochet, M., & Boucher, M. (1968) · PubMed · Cited by 15
Leucoencephalopathy with vanishing white matter may cause progressive myoclonus epilepsy
Jansen, A., Andermann, E., Niel, F., Creveaux, I., Boespflug‐Tanguy, O., & Andermann, F. (2008) · Epilepsia · doi:10.1111/j.1528-1167.2008.01542.x · Cited by 14
Mierzewska, H., van der Knaap, M. S., Scheper, G. C., Jurkiewicz, E., Schmidt-Sidor, B., & Szymańska, K. (2006) · PubMed · Cited by 14
Self-citationVanishing white matter disease in a child presenting with ataxia
Wilson, C. J., Pronk, J. C., & van der Knaap, M. S. (2005) · Journal of Paediatrics and Child Health · doi:10.1111/j.1440-1754.2005.00540.x · Cited by 13
Matsui, M., Mizutani, K., Ohtake, H., Miki, Y., Ishizu, K., Fukuyama, H., Shimohata, T., Onodera, O., Nishizawa, M., Takayama, Y., et al. (2006) · European Neurology · doi:10.1159/000097120 · Cited by 12
Late onset vanishing white matter disease
Riecker, A., Nägele, T., Henneke, M., & Schöls, L. J. (2007) · Journal of Neurology · doi:10.1007/s00415-006-0306-9 · Cited by 12
[Cavitary orthochromatic leukodystrophy with oligodendroglial changes. A sporadic adult case].
Graveleau, P., Gray, F., Plas, J., Graveleau, J., & Brion, S. (1985) · PubMed · Cited by 12
Horzinski, L., Gonthier‐Guéret, C., Rodriguez, D., Scherer, C., Boespflug‐Tanguy, O., & Fogli, A. (2008) · Annals of Human Genetics · doi:10.1111/j.1469-1809.2007.00427.x · Cited by 11
Atypical presentation of vanishing white matter disease
Fontenelle, L. M. C., Scheper, G. C., Brandão, L. A., & van der Knaap, M. S. (2008) · Arquivos de Neuro-Psiquiatria · doi:10.1590/s0004-282x2008000400022 · Cited by 10
Self-citationVanishing White Matter Disease Associated with Progressive Macrocephaly
Pineda, M., Rodríguez‐Palmero, A., Baquero, M., O’Callaghan, M., Aracil, A., van der Knaap, M. S., & Scheper, G. C. (2008) · Neuropediatrics · doi:10.1055/s-2008-1076738 · Cited by 9
Self-citationPeripheral Neuropathy in a Child With Cree Leukodystrophy
Huntsman, R. J., Seshia, S. S., Lowry, N., Lemire, E., & Harder, S. L. (2007) · Journal of Child Neurology · doi:10.1177/0883073807304010 · Cited by 7
Vanishing White Matter Disease: The First Reported Chinese Patient
Wong, S. S.-N., Luk, D. C. K., Wong, V. C. N., Scheper, G. C., & van der Knaap, M. S. (2007) · Journal of Child Neurology · doi:10.1177/0883073808314154 · Cited by 5
Self-citation[Clinical characteristics of cases with leukoencephalopathy with vanishing white matter].
Wu, Y., Jiang, Y.-W., Qin, J., Xiao, J., Wang, J., Yang, Y., Zhang, Y.-H., Chang, X., Lin, Q., & Wu, X.-R. (2007) · PubMed · Cited by 4
Myelinopathia centralis diffusa (vanishing white matter disease) in a four-year-old boy
Sinzig, J., Seitz, A., Brockmann, K., & König, S. A. (2004) · Journal of Neuroradiology · doi:10.1016/s0150-9861(04)96981-7 · Cited by 2
Research works printed but not linked: 4
- 10.1097/63.6.618 · doi:10.1097/63.6.618
- Van, 1999, Phenotypic variation in eukoencephalopathy with vanishing white matter, Reply from the authors. Neurology, 53, 1373
- Macchi, 1968, Su d un caso di leucopatia spongio-cavitaria, Acta Neurol, 24, 565
- Hinnebusch AG . Mechanism and regulation of initiation methionyl-tRNA binding to ribosomes. In: Sonenberg N Hershey JWB Mathews MB , eds. Translational Control of Gene expression . Cold Spring Harbor: Cold Spring Harbor Laboratory Press, 2000:185–243
Cited by
Myelination of the Nervous System: Mechanisms and Functions
Nave, K.-A., & Werner, H. B. (2014) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-100913-013101 · Cited by 983
Myelin in the Central Nervous System: Structure, Function, and Pathology
Stadelmann, C., Timmler, S., Barrantes-Freer, A., & Simons, M. (2019) · Physiological Reviews · doi:10.1152/physrev.00031.2018 · Cited by 728
Eukaryotic Initiation Factor 2 Phosphorylation and Translational Control in Metabolism
Baird, T. D., & Wek, R. C. (2012) · Advances in Nutrition · doi:10.3945/an.112.002113 · Cited by 469
Oligodendrocyte‐microglia cross‐talk in the central nervous system
Peferoen, L., Kipp, M., van der Valk, P., van Noort, J. M., & Amor, S. (2014) · Immunology · doi:10.1111/imm.12163 · Cited by 438
van der Knaap, M. S., & Bugiani, M. (2017) · Acta Neuropathologica · doi:10.1007/s00401-017-1739-1 · Cited by 403
“Microscopically, the affected white matter shows lack of myelin, myelin vacuolation, cystic changes, and only rarely loss of myelin with macrophages, arguing against demyelination [29].”
BackgroundInfluentialSelf-citation
Metadata
- Authors
- Bugiani, M., Boor, I., Powers, J. M., Scheper, G. C., & van der Knaap, M. S.
- Affiliations
- University of Rochester Medicine (US)
- Venue
- Journal of Neuropathology & Experimental Neurology
- Publisher
- Oxford University Press (OUP)
- Published
- 2010-10
- Volume
- 69
- Issue
- 10
- Pages
- 987-996
- ISSN
- 0022-3069 (ISSN-L)
- 1554-6578
- OpenAlex
- W2163139716
- Cited by
- 189
- References
- 109
- Citations by year
- 2026: 8 · 2025: 6 · 2024: 16 · 2023: 12 · 2022: 9 · 2021: 13 · 2020: 12 · 2019: 17 · 2018: 14 · 2017: 13 · 2016: 6 · 2015: 9 · 2014: 17 · 2013: 10 · 2012: 17
- FWCI
- 1.00
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Neuropathology & Experimental Neurology (publishedVersion)
- PubMed (publishedVersion)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
- VU Research Portal (publishedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Digital Academic REpository of VU University Amsterdam (Vrije Universiteit Amsterdam) (submittedVersion)
- Funders
- ZonMw (9120.6002)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Hereditary Neurological Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Endoplasmic Reticulum Stress and Disease
- Keywords
- vanishing white matter disease, leukoencephalopathy, eIF2B, oligodendrocyte apoptosis, cerebellar ataxia, unfolded protein response, stress-induced neurodegeneration, cystic degeneration
- MeSH terms
- Glycine, Humans, Nerve Fibers, Myelinated, Eukaryotic Initiation Factor-2B, Leukoencephalopathies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.